HOME >> BIOLOGY >> NEWS
Tiny molecules have big potential as cancer drugs, Stanford researcher believes

PHILADELPHIA Many cancer therapies take a "big stick" approach, targeting rapidly dividing cells in the body to stop malignancies in their tracks but often triggering horrible side effects in the process. New research from the Stanford University School of Medicine points toward the possibility of a different type of cancer drug small molecules that would home in on the proteins tumors need without poisoning patients.

Matthew Bogyo, PhD, assistant professor of pathology, will discuss his studies of some of these molecules at an Aug. 24 talk during the "Genomic Approaches to Enzymology" session of the American Chemical Society's national meeting in Philadelphia.

Previous studies have shown that an increase of certain proteins, called cathepsin cysteine proteases, is associated with tumor development. "People have shown that more of the cathepsins are present in cancers and that they appear to be secreted by cancer cells," said Bogyo. "The question is what are they doing and does it help to block them?" To find out, Bogyo and colleagues used fluorescent tags to track cathepsin activity in mouse models of two types of cancer. They found the cathepsins helped build blood vessels to the tumors as well as increase tumor growth and invasiveness.

The team also tried giving a broad-spectrum cathepsin inhibitor to some cancerous mice and found that it slowed tumor development both in early and late stages of growth with no apparent side effects. The National Cancer Institute has since fast-tracked the inhibitor into studies of toxicity and pharmacodynamics as a potential drug. Meanwhile the research group has used the compound as a jumping-off point, testing similar compounds to find those that bind specifically to "problem" cathepsins, instead of to all of them. Bogyo is also looking for additional molecules that have better potency and pharmacodynamic properties.

Bogyo will give details on tests of some of these molecules at his presentatio
'"/>

Contact: Mitzi Baker
mitzibaker@stanford.edu
650-725-2106
Stanford University Medical Center
24-Aug-2004


Page: 1 2

Related biology news :

1. Synthesized molecules studied as weapon to stop cell division in cancer cells
2. Scientists reinvent DNA as template to produce organic molecules
3. Sweet success in targeting sugar molecules to cells in living animals
4. UC Riverside researcher takes snapshots of the movement of molecules in a billionth of a second
5. Scientists pinpoint molecules that generate synapses
6. Two molecules work together to aid transport of immune cells, UT Southwestern researchers find
7. Controlling biomolecules with magnetic tweezers
8. Water molecules clump more loosely than previously thought
9. Creating polymers that act like biomolecules
10. A new way to see DNA (and other tiny molecules)
11. St. Jude shows how disorderliness in some proteins lets them interact with a diversity of molecules

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/25/2018)... , ... December 24, 2018 , ... ... The Rockefeller University have discovered a new use for a long-standing computational concept ... spam control, blocking unwanted files and messages. Using blacklisting as a filter to ...
(Date:12/20/2018)... TRIANGLE PARK, N.C. (PRWEB) , ... December 20, ... ... have been enhanced through upgraded processes and the completion of a new usability/observation ... Evaluations with the goal of ensuring medical devices and drug delivery devices/combination products ...
(Date:12/19/2018)... ... ... InTouchMD’s flagship product, Pulse , has been honored by PM360 as ... featuring the recognition in its 7th annual Innovations issue, created for purpose of recognizing ... device industries. , “This recognition comes at an exciting time for Pulse as we’re ...
Breaking Biology News(10 mins):
(Date:1/4/2019)... PARK, N.C. (PRWEB) , ... January 04, 2019 ... ... organization, is pleased to welcome Ted Hoffman to the firm. Ted will be ... years of experience working in and providing consulting services to the pharmaceutical industry. ...
(Date:12/19/2018)... (PRWEB) , ... December 19, 2018 , ... ... procedures at its first rate Stem Cell Training Course in Las Vegas. Training ... women. As regenerative procedures explode in popularity nationwide for aesthetics, having the training ...
(Date:12/14/2018)... , ... December 14, 2018 , ... ... Canada Inc., have been given the green light to immediately begin a clinical ... (AMD). , The medical devices bureau of Health Canada has granted what is ...
(Date:12/10/2018)... ... December 10, 2018 , ... ... and Manufacturing Organization (CDMO) with sites in China and the United States, ... aseptic fill finish solutions for monoclonal antibody (mAb) and antibody-drug conjugate (ADC) ...
Breaking Biology Technology:
Cached News: